BARCLAYS PLC - KARUNA THERAPEUTICS INC ownership

KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 248 filers reported holding KARUNA THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.56 and the average weighting 0.9%.

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of KARUNA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$12,500
-31.6%
73,922
-12.3%
0.01%
-33.3%
Q2 2023$18,283
+115.5%
84,316
+80.5%
0.01%
+200.0%
Q1 2023$8,484
+46.6%
46,709
+58.6%
0.00%
+33.3%
Q4 2022$5,786
-99.9%
29,445
-5.3%
0.00%
-62.5%
Q3 2022$6,994,000
+2185.6%
31,098
+1187.2%
0.01%
Q2 2022$306,000
-75.6%
2,416
-75.6%
0.00%
-100.0%
Q1 2022$1,256,000
-88.2%
9,909
-87.8%
0.00%
-50.0%
Q4 2021$10,618,000
+357.9%
81,056
+327.7%
0.00%
+100.0%
Q3 2021$2,319,000
+17.0%
18,953
+9.1%
0.00%0.0%
Q2 2021$1,982,000
-45.6%
17,373
-42.7%
0.00%
-50.0%
Q1 2021$3,642,000
-12.0%
30,303
-25.6%
0.00%0.0%
Q4 2020$4,137,000
+549.5%
40,723
+393.8%
0.00%
Q3 2020$637,000
-38.5%
8,247
-11.3%
0.00%
-100.0%
Q2 2020$1,035,000
+277.7%
9,295
+144.7%
0.00%
Q1 2020$274,000
-29.2%
3,799
-26.0%
0.00%
Q4 2019$387,000
+945.9%
5,137
+127.5%
0.00%
Q3 2019$37,0002,2580.00%
Other shareholders
KARUNA THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Pivotal bioVenture Partners Investment Advisor LLC 782,008$169,578,43555.90%
Nan Fung Group Holdings Ltd 225,688$48,940,44331.28%
Sofinnova Investments, Inc. 1,381,149$299,502,16119.62%
Paradigm Biocapital Advisors LP 283,605$61,499,7444.75%
First Light Asset Management, LLC 208,746$45,266,5703.55%
Avidity Partners Management LP 442,200$95,891,0703.35%
CATALYST PRIVATE WEALTH, LLC 21,837$4,735,3532.97%
Rock Springs Capital Management LP 493,527$107,021,3302.55%
Boxer Capital, LLC 250,000$54,2132.51%
DAFNA Capital Management LLC 42,173$9,145,2152.50%
View complete list of KARUNA THERAPEUTICS INC shareholders